Forma Therapeutics to Report Fourth Quarter and Year-end 2020 Financial Results and Provide Business Update on March 30, 2021
Forma Therapeutics Holdings (Nasdaq: FMTX) plans to release its fourth quarter and year-end 2020 financial results on March 30, 2021. The company will host a conference call for the investment community at 8 a.m. Eastern Time on the same day to discuss these results and provide updates on its business operations. Investors can participate by dialing specific numbers for U.S. and international participants or by accessing a live webcast on the company’s official website.
- Upcoming financial results for Q4 and year-end 2020 may indicate company growth.
- Conference call scheduled for March 30, 2021, provides opportunity for investor insights.
- None.
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that it will release fourth quarter and year-end 2020 financial results Tuesday, March 30, 2021. Forma management will host an investment community conference call at 8 a.m. Eastern Time, on March 30, 2021, to discuss these financial results and provide a business update.
Investors may participate by dialing (833) 301-1146 in the U.S. or Canada, or (914) 987-7386 internationally, and by referring to Conference ID 5893542. A live webcast of the conference call will be available in the “News & Investors” section of Forma’s website at www.formatherapeutics.com.
About Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. For more information, please visit www.FormaTherapeutics.com or follow us on Twitter @FORMAInc and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005971/en/
FAQ
When will Forma Therapeutics release its financial results for Q4 2020?
What time is the Forma Therapeutics conference call on March 30, 2021?
How can investors participate in the Forma Therapeutics conference call?